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Abstract
This thesis studies human gene expression space using high throughput
gene expression data from DNA microarrays. In molecular biology, high
throughput techniques allow numerical measurements of expression of tens
of thousands of genes simultaneously. In a single study, this data is tradi-
tionally obtained from a limited number of sample types with a small num-
ber of replicates. For organism-wide analysis, this data has been largely
unavailable and the global structure of human transcriptome has remained
unknown.
This thesis introduces a human transcriptome map of different biological
entities and analysis of its general structure. The map is constructed from
gene expression data from the two largest public microarray data reposito-
ries, GEO and ArrayExpress. The creation of this map contributed to the
development of ArrayExpress by identifying and retrofitting the previously
unusable and missing data and by improving the access to its data. It also
contributed to creation of several new tools for microarray data manipula-
tion and establishment of data exchange between GEO and ArrayExpress.
The data integration for the global map required creation of a new large
ontology of human cell types, disease states, organism parts and cell lines.
The ontology was used in a new text mining and decision tree based method
for automatic conversion of human readable free text microarray data anno-
iii
iv
tations into categorised format. The data comparability and minimisation
of the systematic measurement errors that are characteristic to each lab-
oratory in this large cross-laboratories integrated dataset, was ensured by
computation of a range of microarray data quality metrics and exclusion of
incomparable data. The structure of a global map of human gene expres-
sion was then explored by principal component analysis and hierarchical
clustering using heuristics and help from another purpose built sample on-
tology.
A preface and motivation to the construction and analysis of a global map
of human gene expression is given by analysis of two microarray datasets of
human malignant melanoma. The analysis of these sets incorporate indirect
comparison of statistical methods for finding differentially expressed genes
and point to the need to study gene expression on a global level.
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I.1.5.3 Pattern recognition: Custering - Algorithms, Similarity measures
J.3 Life and medical science
General Terms:
bioinformatics, DNA microarrays, data analysis, systems biology
Additional Key Words and Phrases:
gene expression, data integration, exploratory data analysis, clustering,
principal component analysis, distance metrics, malignant melanoma,
human
Acknowledgements
My first and foremost gratitude goes to my advisor Professor Esko Ukkonen
for accepting me as a student in ComBi graduate school and supporting
me through out the years of my development as bioinformatician. I am
equally grateful to Dr. Alvis Brazma for having me as a permanent visitor
in his group at European Bioinformatics Institute (EBI) and for becoming
my second unofficial adviser. My gratitude also goes to Dr. Erkki Ho¨ltta¨
for his guidance and interesting discussions about melanoma biology.
I would like to thank the staff of the department of Computer Science
for the excellent education they provide. A warm thank you to my office
mate Dr. Kimmo Palin who served as a faithful companion and an ultimate
information source of computer science, statistics, mathematics and general
information of the department and life in Helsinki.
At EBI, I would like to thank Dr. Helen Parkinson and her curation
team teaching me about ArrayExpress database and for creating the best
imaginable working environment. I would also like to thank Dr. Parkinson
for reading and commenting on the manuscript of this thesis. My thanks
also goes to all members and visitors of the ArrayExpress team over the
years for their influence to the work in this thesis. I am thankful to Dr.
Samuel Kaski for his encouragement in thinking towards future scientific
issues.
I want thank my collaborators in Finland, UK and Germany throughout
the years. I am especially grateful for Dr. Janne Nikkila¨ who introduced
me to R/Bioconductor and to Dr. Tim Rayner for his influence to my
Perl skills. I would like to thank all of the funding bodies on both sides of
English channel that supported the work.
My gratitude goes to ComBi coordinator Heikki Lokki for his help in
administrative matters over email while I was living in UK. I would like to
thank Dr. Katja Kivinen for helping me with the language for the Finnish
abstract of this thesis. Similarly, I am grateful to the BREW workshops for
providing invaluable experience in scientific writing and presentation skills
in the earlier years of my studies.
v
vi
My gratitude goes to my parents Anne and Heino, and my brothers
Toomas and Tiit for their support and encouragements throughout this
thesis. Finally, I want to thank my dear wife Dawn-Louise and our two
sons Daniel and Andreas for their constant and never ending love.
Cambridge, July 15, 2010
Margus Lukk
vii
This thesis is based on the following papers, which are referred in the text
by their Roman numbers:
I E Ka¨a¨ria¨inen, P Nummela, J Soikkeli, M Yin, M Lukk, T Jahkola, S
Virolainen, A Ora, E Ukkonen, O Saksela and E Ho¨ltta¨. Switch to
an invasive growth phase in melanoma is associated with tenascin-C,
fibronectin, and procollagen-I forming specific channel structures for
invastion. The Journal of Pathology 2006 Oct;210(2):181-91.
II J Soikkeli1, M Lukk1, P Nummela, S Virolainen, T Jahkola, R Katainen,
L Harju, E Ukkonen, O Saksela and E Ho¨ltta¨. Systematic search for
the best gene expression markers for melanoma micrometastasis detec-
tion. The Journal of Pathology 2007 Oct;213(2):180-9.
III H. Parkinson, M. Kapushesky, M. Shojatalab, N. Abeygunawardena,
R. Coulson, A. Farne, E. Holloway, N. Kolesnykov, P. Lilja, M. Lukk,
R, Mani, T. Rayner, A. Sharma, E. Williams, U. Sarkans and A.
Brazma. ArrayExpress–a public database of microarray experiments
and gene expression profiles. Nucleic Acids Research 2007 Jan;35
(Database issue):D747-50.
IV Tim F. Rayner, Faisal Ibne Rezwan, Margus Lukk, Xiangqun Zheng
Bradley, Anna Farne, Ele Holloway, James Malone, Eleanor Williams
and Helen Parkinson. MAGETabulator, a suite of tools to support
the microarray data format MAGE-TAB. Bioinformatics 2009 Jan
15;25(2):279-80.
V Audrey Kauffmann, Tim F. Rayner, Helen Parkinson, Misha Kapush-
esky, Margus Lukk, Alvis Brazma and Wolfgang Huber. Importing Ar-
rayExpress datasets into R/Bioconductor. Bioinformatics 2009 Aug
15;25(16):2092-4.
VI Margus Lukk, Misha Kapushesky, Janne Nikkila¨, Helen Parkinson,
Angela Goncalves, Wolfgang Huber, Esko Ukkonen and Alvis Brazma.
A global map of human gene expression. Nature Biotechnology 2010
Apr;28(4):322-324
1These authors contributed equally to this work.
viii
Contents
1 Introduction 1
1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Summaries of original publications . . . . . . . . . . . . . . 2
1.3 Contributions of the author . . . . . . . . . . . . . . . . . . 5
2 Gene expression profiling 9
2.1 Genes and Gene expression . . . . . . . . . . . . . . . . . . 9
2.2 DNA microarrays . . . . . . . . . . . . . . . . . . . . . . . . 10
2.2.1 Dual channel microarrays . . . . . . . . . . . . . . . 12
2.2.2 Single channel microarrays . . . . . . . . . . . . . . 12
2.3 Microarray data standards and formats . . . . . . . . . . . 13
2.3.1 Formats of gene expression measurements . . . . . . 14
2.3.2 MIAME . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.3.3 MGED Ontology . . . . . . . . . . . . . . . . . . . . 15
2.3.4 MAGE and MAGE-TAB . . . . . . . . . . . . . . . 15
2.4 Public microarray data repositories . . . . . . . . . . . . . . 16
2.4.1 GEO and ArrayExpress . . . . . . . . . . . . . . . . 16
3 Microarray data integration 19
3.1 Challenges of microarray data integration . . . . . . . . . . 19
3.1.1 Cross-platform data integration . . . . . . . . . . . . 20
3.1.2 Integration in rank space . . . . . . . . . . . . . . . 21
3.2 Integration of experimental meta-data . . . . . . . . . . . . 22
3.3 Quality assessment of microarray data . . . . . . . . . . . . 24
3.3.1 Quality assessment of Affymetrix data . . . . . . . . 25
3.3.2 Affymetrix standard quality metrics . . . . . . . . . 26
3.3.3 The probe level model derived quality measures . . . 26
3.4 Integration and data quality . . . . . . . . . . . . . . . . . . 28
3.5 Factors proposed to affect the quality of microarray data . . 29
ix
x Contents
4 Microarray data analysis 31
4.1 Distance and correlation . . . . . . . . . . . . . . . . . . . . 31
4.2 Clustering methods . . . . . . . . . . . . . . . . . . . . . . . 33
4.2.1 Hierarchical clustering . . . . . . . . . . . . . . . . . 33
4.2.2 K-means clustering . . . . . . . . . . . . . . . . . . . 35
4.3 Differential expression . . . . . . . . . . . . . . . . . . . . . 36
4.3.1 Student’s t-test . . . . . . . . . . . . . . . . . . . . . 36
4.3.2 T-test derivatives . . . . . . . . . . . . . . . . . . . . 36
4.3.3 Permutation test . . . . . . . . . . . . . . . . . . . . 37
4.3.4 Multiple testing . . . . . . . . . . . . . . . . . . . . . 38
4.4 Principal component analysis . . . . . . . . . . . . . . . . . 38
5 Analysis of human melanoma data 41
5.1 Sentinel lymph node based melanoma diagnostics . . . . . . 41
5.2 A global search of metastatic melanoma specific marker genes 42
5.3 For the justification of fold change usage . . . . . . . . . . . 43
6 Summary and Conclusions 45
References 49
Reprints of original publications 59
Contents xi
Abbreviations
ANOVA - Analysis of variance
cDNA - Complementary deoxyribonucleic acid
CIBEX - Center for information biology gene expression database
cRNA - Complementary ribonucleic acid
Cy3 - Cyanine 3
Cy5 - Cyanine 5
DDBJ - DNA data bank of Japan
DNA - Deoxyribonucleic acid
EBI - European bioinformatics institute
EFO - Experimental factor ontology
GEO - Gene expression omnibus
MAGE - Microarray and gene expression
MAGE-ML - Microarray gene expression - markup language
MAGE-OM - Microarray gene expression - object model
MAGE-TAB - Microarray gene expression tabular
MAGEstk - Microarray gene expression software toolkit
MAQC - Microarray quality control
MAS5 - Microarray suite version 5
MGED - Microarray gene expression data society
MIAME - Minimum information about a microarray experiment
miRNA - Micro ribonucleic acid
MM - Mismatch
mRNA - Messenger ribonucleic acid
NCBI - National centre for biotechnology information
NUSE - Normalised unscaled standard error
PCA - Principal component analysis
PCR - Polymerase chain reaction
PLM - Probe level model
PM - Perfect match
RLE - Relative log expression
RMA - Robust multi-array average
RNA - Ribonucleic acid
RNA-seq - Ribonucleic acid sequencing
rRNA - Ribosomal ribonucleic acid
RT-PCR - Reverse transcription-polymerase chain reaction
S2N - Signal to noise
SAM - Significance analysis of microarrays
SOFT - Simple omnibus format in text
SOM - Self-organizing map
xii Contents
tRNA - Transfer ribonucleic acid
UHTS - Ultra high throughput sequencing
UML - Unified modelling language
UMLS - Unified medical language system
WTSS - Whole transcriptome shotgun sequencing
XML - Extensible markup language
Chapter 1
Introduction
”In theory there is no difference between theory and practice.
In practice there is.”
Yogi Berra
1.1 Motivation
This thesis is about processing and analysis of microarray data. Microar-
ray data analysis is a branch of bioinformatics which is an application of
information technology and computer science to the field of molecular biol-
ogy. The biological questions that motivate this thesis include: (1) which
of the genes are involved in the escape of melanoma cells from the primary
tumour during metastasation?; (2) which of the genes could be used to
detect the progression of melanoma cells to the sentinel lymph nodes?; and
ultimately, (3) how are different cell types organised in the human gene
expression space?
These biological questions have scientific value for the following reasons:
Firstly, the formation of metastasis in malignant melanoma is not well
understood. It is known that the cells of a primary tumour undergo a
transition which allow them to leave via lymphatic system. The mechanism
and genes it involves have remained unknown. Secondly, the early detection
of invasive melanoma cells in sentinel lymph nodes has an important impact
on survival. Many genes with melanoma specific expression have been
proposed for detection of the presence of melanoma cells in the sentinel
lymph nodes; but no consensus of which genes should be used in clinical
tests has been established. Most importantly, no transcriptome wide search
for such genes has been carried out. Finally, similarly to the first two
questions, transcriptional states of human cells are largely studied only in
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the context of a small number of other, and often related, cell and tissue
types e.g. disease vs. normal. A global view of which genes are expressed
where and how the expression differs between different cell states in the
context of a whole organism is non-existent. The data for answering such
question has not been available to date. This thesis addresses this need.
The first two motivating questions relate to melanoma biology while the
last one is more general. The link between these questions is the microarray
data and the use of similar analysis methods. However, it was the research
undertaken with the first two questions that raised the issues of the third.
Addressing complete gene expression between different cell types is impor-
tant but more so is to compare a cell type against all other cell and tissue
types in the organism. It is this question of the global structure of human
gene expression which is the most complex and underpins this thesis.
Primarily, this thesis aims to address these biological questions through
the use of computational analysis of microarray data. How can these an-
swers be found? Which data processing and analysis methods should be
used? What alterations to the methods are required to apply these to quan-
tities of data on which they have never been applied before? Where can we
obtain more microarray data, how can it be integrated for co-analysis, and
how to assure its comparability? How can we visualise the results? These
are just some of the problems for which this introduction tries to provide
answers.
1.2 Summaries of original publications
Short summaries of original publications included in this thesis are given
below.
Paper I
Paper I is the study of molecular mechanisms behind the escape of
melanoma cells from the site of primary tumour. We start by measur-
ing gene expression in samples of benign nevi, primary melanomas,
and melanomas with known metastasis using different microarray
platforms. The pre-processing of the numerical data and subsequent
search for genes which are highly up-regulated in the invasive phase of
the cancer is carried out for each microarray platform separately. The
three extracellular matrix proteins encoding genes tenascin-C (TN-
C), fibronectin (FN) and procollagen-I (PCOL-I) identified during
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the analysis are then used for immunohistochemical staining to lo-
calise their expression in the tumour. We show that all three proteins
co-localise in the tumour and form tubular meshworks and channels
ensheathing the melanoma cells.
Paper II
The focus of Paper II is the search and selection of genes that are
specifically expressed in metastatic melanoma for construction of RT-
PCR based clinical assay that could be used for detection of invaded
melanoma cells in sentinel lymph nodes either in parallel with, or as
replacement of, the immunohistochemical examination.
We measure the gene expression of biological replicates of groups of
benign nevi as well as normal, micro metastatic and macro metastatic
lymph nodes using two different microarray platforms. The expres-
sion values from both platforms are quantified and merged into one
virtual microarray using a small set of control transcripts shared be-
tween both of the arrays. The data is processed further by a version
of quantile normalisation specially implemented for this paper. Fi-
nally the data is filtered to include genes with sufficient group wise
separation.
The robustness of the set of differentially expressed candidate genes
suitable for the clinical assay is ensured by the parallel use of multi-
ple statistical tests and methods suggested for these types of analysis
in the literature. A tool for computing signal to noise (S2N) val-
ues and associated p-values using permutation test in this paper was
implemented according to [GST+99].
We then test the set of candidate genes for the assay parallel to im-
munohistochemical analysis on a body of sentinel lymph nodes. We
conduct a statistical analysis of the results and show that two of the
genes tested in the reverse transcription-polymerase chain reaction
(RT-PCR) assay perform better, as assessed by disease recurrence,
than histological and immunohistochemical examination of the lymph
nodes. The statistical analysis also identifies two further melanoma
specific marker genes which are capable for differentiating between
melanoma cells and cells of benign nevi in the sentinel lymph nodes.
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Paper III
In Paper III we present an update on ArrayExpress which is one of
the leading gene expression data repositories in the world [ItHV+08].
The update introduces a new query interface for simpler data search
and retrieval both in ArrayExpress repository and in data warehouse;
and new tools developed for easier data submission. The update in-
cludes also a retrofit of majority of Affymetrix native format data
files which had been corrupted while being loaded to ArrayExpress.
Paper IV
Paper IV is a report of a set of software tools to support new mi-
croarray gene expression tabular (MAGE-TAB) data format. The
software suite includes tools for preparation, syntactic and semantic
validation of the data presented in MAGE-TAB format, visualisation
of investigation designs coded in MAGE-TAB, conversion of MAGE-
TAB documents to older microarray gene expression markup language
(MAGE-ML) format, conversion of Gene Expression Omnibus (GEO)
Simple Omnibus Format in Text (SOFT) format data files to MAGE-
TAB and post hoc addition of ontology terms to existing MAGE-TAB
documents.
The significance of the tools presented in this paper lies in the fact
that MAGE-TAB format has been proposed by the microarray com-
munity to replace the more complex MAGE-ML data format. The
tools in this software suite have also made it possible to start public
microarray data exchange between GEO and ArrayExpress. MAGE-
TAB has already been established as new official data export format
in ArrayExpress and will be the main microarray data import/export
format for the next generation ArrayExpress database.
Paper V
In Paper V we present a new software package for direct access of
ArrayExpress data from R statistical language environment. The
package allows users to browse and work with ArrayExpress data in
R environment without external downloading and complex data for-
matting. The package uses MAGE-TAB formatted data from Array-
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Express ftp site and converts it to R data objects; a convenient input
to many microarray data analysis tools available in R/Bioconductor
project.
Paper VI
In Paper VI we present a global map of human gene expression. We
study the difference and distance of the gene expression between a
large number of cell states, types and lines. We visualise this infor-
mation by the first principal components of the data and call the
identified global level results a global map of human gene expression.
We identify six major ’continents’ on this map and characterise their
content and relations.
The data for the map was collected from public microarray data in
ArrayExpress and GEO. Strict data quality control was performed
and in the case of GEO, the data was subjected to a semi-automatic
text mining based meta data re-annotation. To present and group the
data in a more meaningful way, we organised the sample annotations
into a custom ontology and used this in data visualisation by hierar-
chical clustering and principal component analysis (PCA). As some of
the tools and methods that we used were created for datasets several
magnitudes smaller than in this paper, the computation and visuali-
sation was possible only with the help of various heuristics. We also
analysed several subgroups of the data both in sample and in gene di-
mension. We computed gene ontology enrichments for selected gene
groups and identified differentially expressed genes between groups
of samples. Finally, we created a web interface with a set of query
options for more specific exploration of the data.
1.3 Contributions of the author
Main contributions of this thesis in publication order:
I The paper identifies three extracellular matrix protein encoding genes
which play a role in the escape of the melanoma cells from the primary
tumour. The paper also proposes a new concept of structured tumour
cell spreading in melanoma via formation of special channel-like struc-
tures observed by usage of immunohistochemistry. The author con-
tributed to the paper via processing and analysis of different types
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of the melanoma gene expression data which lead to identification of
these three genes.
II The paper reports the first genome-wide search for the best gene ex-
pression markers to detect melanoma micrometastasis. The paper con-
firms the good performance of genes TYR and MLANA in clinical RT-
PCR based metastatic melanoma cell detection assay and identifies
two other genes PRAME and SPP1 as novel malignancy indicators
and ideal therapy targets in metastatic melanoma. The author per-
formed the microarray data processing and analysis to identify good
candidate genes for the assay; and the statistical analysis of the RT-
PCR data. Together with Dr. Erkki Ho¨ltta¨, the author interpreted
the biological data and selected the candidate genes for the RT-PCR
assay.
III The paper presents the update of the latest improvements in Array-
Express which include introduction of the new user friendly database
browse and query interface, a report of starting to serve the data in
the database ftp site for bulk downloads and introduction of new data
submission tools. The main contribution of the author was taking a
lead in the re-design of the ArrayExpress web interface for improved
data access and display. The author also contributed through analy-
sis of ArrayExpress user behaviour using database web server log files,
through retrofit of majority of the Affymetrix CEL files in the database
from various sources as these had been corrupted while being loaded
to the database; and through testing of the new interfaces and data
submission tools.
IV The paper introduces a series of MAGE-TAB data format related soft-
ware tools which are critical for the every day operation of Array-
Express. The main contribution of the author was the design and
implementation of the custom ontology based text mining application
to discover microarray gene expression data society ontology (MGED
ontology) based category values in GEO free text annotations. The au-
thor also provided input to the development of GEO to ArrayExpress
data importer which is continuously used for mirroring GEO data in
ArrayExpress.
V The paper introduces a software package for data retrieval from Array-
Express to R statistical language environment. The author contributed
to the testing of the software and adjusted the software for the internal
use of ArrayExpress.
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VI The paper introduces and characterises a first global map of human
gene expression and provides a web interface for detailed exploration
of the underlying data. The presented work is also an example of
successful large scale microarray data integration. The contributions
of the author include choosing the topic, creating all necessary tools for
the data integration, integrating the data, performing the data quality
check and filtering of the data based on the quality and performing
majority of the presented data analysis and visualisation.
* * *
The rest of the thesis is organised as follows. Introduction to gene
expression and gene expression data is given in Chapter 2. Microarray data
integration with its challenges in data selection, integration and quality
assessment for data comparability are discussed in Chapter 3. Microarray
data analysis methods used in different parts of this thesis are outlined
in Chapter 4. The initial work with melanoma data which motivated the
larger part of the included work and became itself secondary is introduced
in Chapter 5. Finally, the introductory part of the thesis is concluded by
Chapter 6 which summarises the main results of this work. The original
publications I-VI are reprinted at the end of the thesis.
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Chapter 2
Gene expression profiling
This chapter is an introduction to genes, gene expression and gene expres-
sion data. Section 2.1 provides a short introduction to genes and gene
expression. Section 2.2 describes two different types of microarrays used in
Papers I, II and VI. Definitions and an overview of microarray data stan-
dards and formats relevant for the rest of the thesis are given in Section
2.3. Finally, Section 2.4 introduces public microarray data repositories and
discusses some of their properties.
2.1 Genes and Gene expression
The genetic information in all known living organisms is stored in deoxyri-
bonucleic acid (DNA) molecules. These molecules contain the complete in-
formation needed for the normal function and reproduction of the organism.
The genomic DNA is divided into locatable functional regions correspond-
ing to a unit of inheritance known as genes. The DNA sequence of a gene
consists of coding sequences which determine what the gene does and reg-
ulatory sequences which determine how the gene is activated. The process
in which the information is copied from genomic DNA to ribonucleic acid
(RNA) is known as transcription. Some of the RNA molecules, particularly
messenger ribonucleic acid (mRNA) molecules, are further translated into
a specific amino acids chain which is then folded into an active protein.
The flow of genetic information from DNA to RNA to protein is known
as the central dogma of molecular biology (Figure 2.1) [Cri70]. The RNA
copy of the gene is referred to as transcript and the expression of all the
genes in a given cell in a given time point is called a transcriptome.
The expression levels of genes vary greatly and depend on many internal
and external factors. The state of the cell at any time point is dependent
9
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Data
Figure 2.1: Central dogma of molecular biology (left). Steps in gene ex-
pression measurement using two colour DNA microarrays (right).
upon, and reflected by, the expression levels of all genes. Studying gene
expression therefore provides information about the cells state in general,
and about the roles of individual genes.
In the majority of studies, the gene expression is measured for only pro-
tein coding genes, i.e. genes from which mRNAs are produced. Studying
mRNA expression is biologically relevant since it indirectly gives informa-
tion on the expression of the proteins which are the key players in a cell.
The expression of ribosomal ribonucleic acid (rRNA) and transfer ribonu-
cleic acid (tRNA) molecules is usually ignored as these are expressed in all
living cells while micro ribonucleic acid (miRNA) expression is measured
by separate dedicated assays. The miRNAs are important for study since
they are known to be post-translational regulators of mRNA.
2.2 DNA microarrays
DNA microarrays (or microarrays) are the most commonly used technol-
ogy for measuring expression levels for thousands of genes in parallel. Al-
ternative low throughput technologies include Northern plotting [AKS77]
and RT-PCR [VVF08]. The high throughput alternatives include SAGE
(serial analysis of gene expression) [VZVK95], cap analysis gene expression
(CAGE) [SKK+03], massively parallel signature sequencing (MPSS)[NH09]
and ribonucleic acid sequencing (RNA-Seq)[WGS09], also known as Whole
Transcriptome Shotgun Sequencing (WTSS).
2.2 DNA microarrays 11
The DNA microarray technology, originally derived from Southern blot-
ting technology [Sou75], is used for detection of specific DNA fragments in a
larger pool of DNA fragments. In Southern blotting, the known DNA frag-
ments are attached to a substrate and probed with sample DNA fragments
to observe which DNA fragment the sample contains. The technology ex-
ploits property of nucleic acid sequences to pair with each other in the
hybridisation reaction based on the principle of complementarity. In the
reaction sample DNA fragments bind to their complements on the sub-
strate. The samples used in the hybridisation, labeled either radioactively
or fluorescently, are then detected by the amount of label.
On a DNA microarray, the substrate typically contains an array of
thousands of DNA fragments with known sequences. The sequences on the
array are designed to complement the mRNA molecules of genes from which
expression is measured. The cocktail of mRNA molecules extracted from
cells under study are reverse transcribed to complementary deoxyribonu-
cleic acids (cDNAs) and labelled with fluorescent tags. The complementary
ribonucleic acid (cRNA) molecules, which are created during the labelling
procedure from cDNAs, are then used in a hybridisation reaction where
each cRNA finds its DNA complement on the array. The amount of cRNA
bound to each DNA fragment (spot/probe) on the array is measured by
exposition of the microarray to a light which causes the labels to fluoresce.
The microarrays are scanned/photographed and the intensities of the flu-
orescent signals for each of the spots on the microarray are quantified to
numerical values of gene expression by image analysis software.
The weaknesses of the DNA microarray technology are the relative
abundance of the measured expression values and limitedness of the re-
sults to only these genes for which the DNA fragments on the array exist.
Moreover, different microarray platforms (array designs) consist of probes
for different lists of genes and/or different DNA sequences for the same
genes. These produce results which are not always comparable even when
the same biological material is measured.
A variety of techniques exist for DNA microarray manufacture. The
sequences of the DNA fragments on the array surface can be spotted or
synthesised in situ. The material spotted on the arrays may be oligonu-
cleotides, cDNA or small fragments of polymerase chain reaction (PCR)
products that correspond to mRNA. Depending on the microarray type,
the location of each DNA fragment on the array may be fixed to a certain
location - the case for most current microarray types, or be dynamic for
example in microarrays manufactured by Illumina Inc.
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2.2.1 Dual channel microarrays
In two-channel (or two-colour) microarrays [SSDB95] [SSB96], cDNA/cRNA
from two differently labelled samples are hybridised on microarray at the
same time (Figure 2.1 b). The fluorescent labels most commonly used in
this type of arrays are Cyanine 5 (Cy5) with fluorescence emission 670 nm
and Cyanine 3 (Cy3) with fluorescence emission 570 nm. The microarray
is scanned for each wavelength separately and the quantified result for each
probe on the array is usually presented as a ratio of fluorophore intensities
in one of the channels over the other. In the hybridisation of two-colour mi-
croarray, the cDNA molecules from both samples are competing for one set
of probes. For each gene/the results therefore show a relative expression
difference between the samples. To make individual hybridisations that
measure different biomaterial comparable, a common reference in one of
the channels is typically used. A low quality sample in one of the channels
can seriously bias the obtained results.
In this thesis, the dual channel microarray data was used in Paper I.
2.2.2 Single channel microarrays
Single channel (or one-colour) microarrays [PSS+94] [LDB+96] use one la-
belled sample per hybridisation. The sensitivity quantified values are abso-
lute for the sample and make the individual hybridisations from the same
microarray platform more easy to compare.
Affymetrix
The current market leader in production of single channel oligonucleotide
microarray platforms is Affymetrix. The sequences on Affymetrix GeneChip
arrays are synthesised in-situ using photolitoghaphic synthesis method de-
veloped by the semiconductor industry [FRP+91] [FRH+93] [PSS+94]. The
sequences for all spots on the array are synthesised one nucleotide at a time
from the bottom of the array. Each transcript on the Affymetrix GeneChip
array is presented by eleven 25 base pair long oligonucleotide probe se-
quences known as a probeset (Figure 2.2). The sequences are designed
from the last 500 base pairs of the 3’ end of the transcript. Each perfect
match (PM) sequence on the array has a mismatch (MM) counterpart that
differs from the first by one nucleotide at the 13th position. The nucleotide
in the middle of the sequence is subject to purine to pyrimidine (and vice
versa) transversion. The purpose of MM probes is to measure non-specific
binding and background noise.
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Perfect Match (PM)
MisMatch (MM)
Probe pairs in probe set
AATGGGTCAGAAGGACTCCTATGTG
AATGGGTCAGAACGACTCCTATGTG
... TGATGGTGGGAATGGGTCAGAAGGACTCCTATGTGGGTGACGAGG ...
Perfect Match Oligo
Mismatch Oligo
Reference sequence
5’ 3’
mRNA reference
DNA probe pairs
Figure 2.2: Affymetrix Genechip design principles.
Methods used in this thesis for Affymetrix probe level intensity quantifi-
cation to probe set level intensities of genes included microarray suite ver-
sion 5 (MAS5) [LMD+02] [HLM02] [IHC+03] in Papers I and II; and robust
multi-array average (RMA) [IBC+03] [IHC+03] [BIAS03] in Paper VI. In
short, both methods contain steps for background correction, probe level in-
tensity calculation and probe set summarisation. Additionally, RMA uses,
before the probe level intensity calculation, a step for arrays wide probe
level normalisation; and MAS5 contains a step for scaling summarised in-
tensities to a mean target intensity. Further differences between the two
methods lie in techniques used in the listed shared steps and in the usage
of only PM probe sets by RMA. The exclusion of MM data in RMA re-
duces noise as well as loses information and reflect in more precise results
and smaller number of false positives. The advantage of MAS5 algorithm
which uses both PM and MM probe sets is in larger variance on the lower
expression levels, sensitivity to real expression changes and no assumption
about equal expression value distributions in different co-analysed biologi-
cal material.
2.3 Microarray data standards and formats
Microarray community wide standards and formats for public microarray
data storage, sharing and exchange are created by the Microarray Gene Ex-
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pression Database (MGED) society. Over its lifetime, the society has intro-
duced standards for content, format, and semantics known as: minimum
information about a microarray experiment (MIAME), MGED Ontology
[WPC+06], microarray and gene expression (MAGE), and more recently
MAGE-TAB [RRSS+06]. The data standards and formats introduced by
the MGED society deal only with the experimental meta-data while the
many formats of actual gene expression measurements have not been reg-
ulated as these are defined by instrumentation and assay vendors. The
experimental meta-data in this thesis is defined as a collection of annota-
tions needed for interpretation of the numerical expression values produced
using DNA microarrays. These data include the general description and
layout of the experiment, text of relevant laboratory protocols and anno-
tations of measured biological samples and assays.
2.3.1 Formats of gene expression measurements
Diversity in both commercial and academic developed microarray technolo-
gies and platforms has prevented the rise of a single common microarray
data file format. The data is, however, generally distinguished as either raw
or processed/normalised/transformed. The raw microarray data is defined
as that produced by microarray image analysis software and contains ini-
tial numerical quantifications of the fluorescent intensities measured on mi-
croarrays. Processed microarray data is defined as raw data which has been
subjected to various data cleaning and smoothing methods which usually
include signal background correction, normalisation and transformation to
a different scale.
The expression data matrix, or in some cases transformed data ma-
trix or final gene expression data matrix, is a reference to a numerical data
matrix of processed microarray data joined across multiple expression mea-
surements. Traditionally the first column and row of the matrix contain
references of measured genes and samples.
2.3.2 MIAME
MIAME describes the Minimum Information About a Microarray Exper-
iment needed for unambiguous interpretation of the results of microarray
experiment and for potential experiment reproduction [BHQ+01]. The up-
dated MIAME check list contains six elements needed for microarray data
based publication:
1. The raw data produced by the microarray image analysis software,
such as CEL files for Affymetrix.
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2. The final processed data for the set of hybridisations in the experi-
ment. For instance MAS5, RMA etc. normalised data matrices for
Affymetrix.
3. The essential sample annotation, including experimental factors and
their values.
4. The outline for the experimental design, including sample data rela-
tionships.
5. Sufficient annotation of the array design in the form of actual DNA
sequences used on the array or database accessions of the sequences
where the probes were designed from.
6. Essential experimental and data processing protocols.
MIAME has been criticised for being merely a guideline rather than
standard and for leaving too much flexibility for individual interpretation
[Bur06]. As a result the amount of information asked by different MI-
AME compliant public microarray repositories for full MIAME compliance
is variable and makes data sharing and comparison across different MIAME
compliant databases complex.
2.3.3 MGED Ontology
The primary purpose of MGED Ontology [WPC+06] is to provide standard
terms for the annotation of microarray experiments. The terms enable
description of how the experiment was performed, provides structure for
defining relationships between individual terms and a list of categories for
describing used biological material. The MGED Ontology is used in devel-
oping software and databases for manipulation and storage of microarray
data.
2.3.4 MAGE and MAGE-TAB
The aim of the MAGE standard is to provide a representation of mi-
croarray expression data for data exchange between different data sys-
tems. The MAGE standard includes the microarray gene expression ob-
ject model (MAGE-OM) modelled in unified modelling language (UML),
the data exchange format MAGE-ML [SMS+02] implemented in extensible
markup language (XML) and microarray gene expression software toolkit
(MAGEstk) - a collection of software packages that act as converters be-
tween MAGE-OM and MAGE-ML.
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In practice, MAGE-ML data format has proven to be over-complicated
and impractical for laboratories with no dedicated bioinformatics support.
A new simpler tab-delimited spreadsheet based format MAGE-TAB to re-
place the MAGE-ML has been introduced [RRSS+06]. The software tools
for MAGE-TAB format microarray data validation, manipulation and con-
version presented in Paper IV have become critical for the operation of
ArrayExpress (Paper III). MAGE-TAB data format is also used for data
import from ArrayExpress to R/Bioconductor in Paper V.
2.4 Public microarray data repositories
The MGED society has promoted all scientific journals to require the sub-
mission of microarray data to public repositories as part of the process
of publication ([BBC+04]. The databases accepted by the MGED soci-
ety for public microarray data deposition are ArrayExpress (Paper III and
[PKK+09]) at European Bioinformatics Institute (EBI), Gene Expression
Omnibus - GEO [BTW+09] in National Center for Biotechnology Informa-
tion (NCBI), and Center of Information Biology gene Expression database
- CIBEX [IIiT+03] hosted by DNA Data bank of Japan (DDBJ).
While the content of corresponding nucleotide databases between EBI,
NCBI and DDBJ is exchanged nightly, until recently no official data ex-
change between central public microarray databases has been agreed. In
November 2009, ArrayExpress and GEO entered into a metadata exchange
agreement for ultra high throughput sequencing (UHTS) experiments which
will appear in both databases regardless of where they were submitted.
Moreover, ArrayExpress has started a one sided data import from GEO
[PKK+09] and has entered into negotiation with CIBEX over MAGE-TAB
format based data exchange. The number of original data submission in
CIBEX is marginal to these available in GEO and ArrayExpress.
2.4.1 GEO and ArrayExpress
Usefulness of microarray data lies in its organisation and accessibility. The
central units of information in GEO are sample/hybridisation and array
platform (array design). Differently from ArrayExpress, the concepts of
sample and hybridisation in GEO are the same. GEO human readable
sample/hybridisation soft files contain free text sample annotations and
links to related raw and processed data files. An experiment SOFT record
contains additional experiment level annotations and links to relevant sam-
ple and related array design records. The central information units in
ArrayExpress are experiment and array design. The data in ArrayExpress
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is currently stored in a 248 table relational database which database model
was automatically generated from MAGE-OM.
Historically, simplicity in the GEO data organisation is best reflected by
the fact that nearly all public microarray data based gene expression studies
have been explicitly carried out using data from this database. Further-
more, retrieval of microarray data from ArrayExpress in a usable form was
difficult before the work invested in Paper III. However, recent improve-
ments in ArrayExpress, such as introduction of MAGE-TAB as a simple
data download format and release of Bioconductor package for direct data
access to R statistical analysis environment (Paper V), have significantly
improved the access to its data.
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Chapter 3
Microarray data integration
This chapter discusses the problem of microarray data integration in Pa-
per VI and the sub-problem of re-annotation of experimental meta-data
in Papers IV and VI. In this thesis, microarray data integration is defined
as usage of data from individual hybridisations, expression profiles or raw
data files across the borders of different microarray experiments. Microar-
ray data integration is often seen only as an integration of numerical values.
The challenge of integration, however, lies both in ensuring comparability of
numerical expression values as well as in consistency of experimental meta-
data and in overall comparability of the integrated data. The last two
data integration points are regularly overlooked. An important question to
ask is which data to use and at which level to integrate. In the integra-
tion approach for Paper VI, the data chosen was raw data created on one
single-channel microarray platform Affymetrix HG-U133A. The rationale
for this approach and clarification for why multi platform data integration
was not considered is given in Section 3.1. The focus of Section 3.2 is on
integration of experimental meta-data. Section 3.3 discusses the assurance
of cross-experiment data quality and comparability and effects that may
reduce the reliability of subsequent meta-analysis of the integrated data.
3.1 Challenges of microarray data integration
Microarray data can be integrated at the level of raw or processed ex-
pression data, within single or across multiple microarray platforms, or on
the level of experimental results with no actual integration of expression
measurements. The ideal data for integration is a raw data from one single-
channel microarray platform. The raw data is free from experiment specific
processing methods, such as normalisation and data transformation which
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may contribute to cross-experiment incomparabilities. The data from a
single channel array platform is free from the problem of potential variable
reference channel. Finally, usage of data from only one microarray plat-
form removes the cross-platform data comparability problem. This ”ideal”
approach is robust [DCD+07] and may require only a routine data qual-
ity/comparability check which unfortunately are often not applied. The
data for integration in Paper VI were selected according to these princi-
ples.
3.1.1 Cross-platform data integration
The data available for any single array platform is, however, limited by the
number of available studies and diversity in measured biological material.
The amount of data available across different array platforms is always
much larger. Moreover, cross-platform data integration has been shown
to deliver biologically meaningful results [RRLG03] [JHE+04] [KAO+08].
Nevertheless, the challenges concealed in cross-platform data integration
are often not given enough attention and are hence briefly discussed below.
A common start point in cross-platform data integration is the probe
mapping between array platforms. The mapping is created by probe anno-
tations or by alignment of probe sequences to a reference genome [RRLG03]
[ELS+05] [KAO+08] [PKK+09]. As vendor supplied microarray probe an-
notations typically originate from the time when particular array was de-
signed, the annotations are often out of date. Therefore, sequence based
re-annotation is preferred.
The cross-platform comparability of expression values is influenced by
individual probe sequence design and its variations between array plat-
forms. Probe sequence composition influences the final expression value
and cross-platform comparability in three different ways. Firstly, the probe
sequences, especially in oligonucleotide arrays, are significantly shorter than
transcripts of genes against which they are designed. Genes in a cell can
be expressed simultaneously as several different transcripts with different
length, exon composition, start and end positions [LTB+09]. A selection of
probe sequence location impacts to mRNA sub populations of a gene mea-
sured by the probe. Secondly, a base pair shift in the genome position for
which probe is designed may have a significant effect on the binding affinity
of the target mRNA. Thirdly, a small change in a probe sequence compo-
sition may change the balance of non-specific binding of other transcripts
to the probe. In the design of any particular array, all three of the effects
are assessed and minimised. Nonetheless, the size of these effects in cross-
platform integration is amplified and hard to predict creating experimental
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noise generated by the array platforms. The problem in cross-platform data
integration is thus minimisation of the noise caused by differences between
array designs with at the same time not compromising the biological signal.
Methods used in tackling the effect of platform differences vary. One
of these, expression data transformation to rank space is described below.
This method was considered in early stages of Paper VI as a universal
method for data normalisation and noise reduction.
3.1.2 Integration in rank space
Microarray data integration in rank space uses the assumption that gene
expression values in any particular biological condition are monotonic and
not influenced by the effects of underlying array platforms. As the order
of expression values is globally fixed, the values in the rank space become
directly comparable. The facts that different microarrays measure slightly
different subsets of genes and in cross-platform comparison, a gene may
have a different expression value, become trivial in rank space.
Let X be a set of all genes and Y and Z sets of genes measured by two
different array platforms such that Y ⊆ X and Z ⊆ X. Let YI and ZI be
subsets of genes in Y and Z shared by both array platforms (YI ≡ ZI).
In monotone transformation of expression values of genes in sets Y and
Z, genes with smallest expression values are assigned rank 1, the second
smallest 2, and so on. Genes with largest expression value are given ranks
m and n equal to the number of elements in Y and Z. In case of monotone
transformation of gene expression values in YI and ZI , ranks of any two
genes measured by different array platforms under same biological condition
should be equal, or in case of some noise, at least close. Similarly, expression
profiles of same biological material should also be alike in rank space.
The advantage of data transformation to rank space lies in simplicity
and no need for further data normalisation. Even though transformation
of expression values to rank space is lossy, it is shown in microarray data
to perform well [XTN+05].
The data transformation to rank space could be seen as a method of
data normalisation where the ranges of individual datasets are made equal.
A similar method for continuous values is quantile normalisation [BIAS03].
In quantile normalisation, the distributions of individual datasets are nor-
malised to an average of all distributions. In this thesis the quantile nor-
malisation was used in Papers II and VI.
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3.2 Integration of experimental meta-data
Microarray meta-data is defined as textual information which is needed
for understanding the origin and essence of the numerical data obtained
by DNA microarrays. Experimental meta-data includes description of the
measured biological material – known as sample annotations; experimental
protocols that describe the origin and processing of the sample material;
and a text for the general outline of the microarray experiment. For exper-
imental meta-data integration, usually only the first two, i.e. sample anno-
tations and experimental protocols used in sample processing, are relevant.
The third, the information about the outline and aim of the experiment is
usually excluded as the origin of numerical expression values is generally
well described already by the first two. In practice also the content of ex-
perimental protocols in meta-data integration is ignored, either because the
texts of the protocols are not available or due to laboriousness of processing
of their content. The effect of experimental protocols on the numerical part
of the experimental data, however, can be reduced by integrating data with
same experimental protocols. This is usually the case while integrating ex-
pression data from single commercial microarray platform which typically
use standard sample processing protocols.
The difficulty in sample annotation integration lies in annotation for-
mat inconsistencies. Ideally all sample annotations are organised around
single well defined format or ontology and use controlled vocabulary. The
real world sample annotations, for example from GEO, however, tend to
have a large free-text component and loose structure which makes auto-
mated sample manipulations and grouping difficult or even impossible. In
such cases, sample annotation integration becomes a problem of natural
language processing and text mining. The process of sample integration is
a problem of sample re-annotation. In previous work, large scale sample
re-annotation has been carried out by the help of the lexical sources such
as Unified Medical Language System (UMLS) and biomedical ontologies
[BK06][FLL+09] while most microarray meta-analysis projects, including
[DCD+07][KAO+08][PKK+09] use manual re-annotation.
Sample meta-data integration for Paper VI was carried out semi auto-
matically by means of initial sample re-annotation for microarray experi-
ments retrieved from GEO was carried out by a specially implemented text
mining system. The initial annotation was then followed by additional man-
ual curation and polishing. The goal for the text mining was to convert the
largely free text GEO annotations to the sample annotation format used
by ArrayExpress. Sample annotations in ArrayExpress are presented in
(category value) pairs with annotation categories originating from MGED
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Sample Characteristics
Sample Source
Sample Title
Sample Description
Term Found?
DiseaseState found?
Experiment Title
Experiment Summary
Experiment Type
Experiment Design
Format result
Y
N
N
N
Y
Y
Figure 3.1: Decision tree from the GEO sample meta-data re-annotation
pipeline in Paper IV. For each sample category, keywords are first searched
from the more informative sections of the annotation text. In case no
keywords are found (N), the search is extended to the less specific parts of
sample annotations and eventually to the experiment annotations.
ontology where each category has a strict meaning. Category Organism-
Part, for instance, would refer to anatomical parts of the organism further
specified by category Organism. The text mining approach in Paper IV and
VI use for each ontology category a separate dictionary of keywords and
keyword matching regular expressions. The dictionaries of keywords and
regular expressions are loaded to a finite state automata which is used to
scan the free text annotations and mark all identified keywords by the cate-
gory to which the particular keyword belongs to. As for each category, the
annotation text may contain several different keywords, we implemented
a decision tree which first looks for keywords in these parts of annotation
text where they are likely to describe the biological sample best (Figure
3.1). In case sample annotations do not contain any keywords, the search
is extended to the description of the experiment where the sample belongs
to because most of the experiments focus only on small number of similar
sample types.
Manual evaluation of the text mining performance showed satisfactory
quality for 68% of the assessed samples. The need for perfect sample quality
forced us to re-check the quality of all re-annotated samples. The speed of
the process of overall re-annotation was, however, significantly boosted by
usage of text mining.
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Mining and analysis of any large expression data set is more efficient if
the relationships and hierarchy between all involved samples are defined.
The concept of ontology or ontology like relationship usage for microarray
sample annotations, however, seems to be relatively new with [FLL+09]
and [KEH+09] being two of few. The need for sample hierarchy was also
recognised in Paper VI and due to lack of any appropriate ontology at the
time, was created semi-automatically from available sources of biological
keywords such as NCI Thesaurus. The appropriate ontology which could
be used in further similar integration projects is the recently created Ex-
perimental Factor Ontology (EFO) [MRBP08]. EFO is designed for anno-
tating microarray experiment samples and has already become important
part of ArrayExpress Atlas [KEH+09]. Usage of these types of ontologies
is essential for large scale microarray data integration, meta-analysis, re-
annotation, grouping and data mining.
3.3 Quality assessment of microarray data
The microarray data quality is often referred to as the quality of expres-
sion measurements. The public microarray data repositories promoted by
MGED society, on the other hand assess the microarray data quality mainly
on the level of meta-data. More explicitly, the data submitted to the repos-
itories is checked manually for MIAME compliance and accepted only on
sufficient level of annotation. Differences in data formats and curation prac-
tice between the data repositories has lead to a condition where a dataset
considered fully MIAME compliant in one of the repositories may not qual-
ify as one in others. ArrayExpress is currently the first and only public mi-
croarray database to score the submitted and integrated experiments based
on their closeness to full MIAME compliance.
Ideally, the quality of a microarray experiment should be a measure of
the quality of meta-data (sample annotations and experimental protocols)
as well as the quality of quantified expression measurements. The quality
assessment of expression measurements depends on particular array plat-
form and often requires methods specific to particular array platform. The
quality of the expression measurements should be checked both within hy-
bridisation and between series of hybridisations that form the experiment
or study. The aim for the first is to detect technical artefacts and biases
within hybridisation while the second focuses on comparability of individual
hybridisations within a study.
Microarray data quality has been assessed by the US Food and Drug
Administration initiative Microarray Quality Control (MAQC) and by Eu-
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ropean Commission Initiative Empowering the Microarray-Based European
Research Area to Take a Lead in Development and Exploitation (EMER-
ALD). Even though both initiatives have commonalities, the main focus
of MACQC project is to develop standard and quality metrics specific for
the use of microarray and next-generation sequencing in clinical practice.
The aim of the EMERALD project is more general and focuses on over-
all microarray data improvement through introduction of best laboratory
practices and establishment of disseminate quality metrics. One of the re-
sults from the EMERALD project is the creation of arrayQualityMetrics
software package [KGH09]. The package is the first to generate universal
microarray data quality reports for the expression values created on the
majority of the microarray platforms.
3.3.1 Quality assessment of Affymetrix data
The quality measures developed for Affymetrix arrays focus mainly on iden-
tification of outliers in a set of arrays. The microarray data quality as a
term in this thesis is relative and dependent on the context where the data
is analysed. More precisely, an array may be an outlier and low quality in
one set of arrays while in the other set it may have a good quality depend-
ing on how comparable the computed quality metrics for all of the arrays
in these sets are.
The typical first step in the quality analysis of single arrays is to examine
the raw probe-level images for spatial artefacts. The analysis is usually
carried out on image plots with logarithmically transformed intensities.
For large studies with hundreds of arrays, examination of individual arrays
may not always be feasible and arrays with spatial artefacts are detected
in a set of arrays by other means [BCB+05].
The basic multi-array quality measures for Affymetrix arrays include
analysis of probe level data by boxblots, histograms and MA-plots. The
boxblot gives a summary of the distribution of probes while the histogram
displays the density functions of raw log-scale probe intensities. Arrays
with significant differences in these plots may be problematic.
Historically MA-plots are used to visualise intensity dependent ratio of
raw microarray data in two channel microarrays. In single-channel arrays,
MA-plots are either computed for all array pairs in the set or each array is
plotted against a common pseudo array constructed from all arrays in the
set. The M and A values are computed for every measured gene as follows
M = log2R− log2G
A =
1
2
∗ (log2R+ log2G)
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where R and G correspond to either intensities of the gene in different chan-
nels of a two channel microarray or intensities of the gene in two different
single channel arrays. The MA-plot uses M in y-axis and A in X-axis. The
scatter plots are further improved by fitted lowess curves to summarise any
non-linear relationships. Arrays with apparent quality problems have os-
cillating lowess smoother, or different variability in the M values compared
to the other arrays.
3.3.2 Affymetrix standard quality metrics
The standard Affymetrix quality metrics used in this thesis include so called
Average Background, Scale Factor, Percent Present and computation of
3′/5′ probe set ratios of RNA quality control genes to measure the RNA
degradation. According to Affymetrix guidelines, the Average Background
values in a set of arrays are recommended to be comparable while the Scale
Factors should lie within 3-fold. The Percent Present values for all arrays
should be similar with extremely low values being a possible indicator of
poor quality. The 3′/5′ probe set ratios for RNA degradation are computed
for a set of RNA quality control genes, such as β-Actin and GAPDH, each
represented by 3 probe sets, one from the 5′ end, one from the middle
and one from the 3′ end of the transcript. The safe threshold for arrays
comparable by 3′/5′ ratios suggested by Affymetrix is 3.
The 3′/5′ ratios in standard Affymetrix quality control are measured
only for few genes and can be quite variable even in high quality data.
Given that probe sets on the Affymetrix array contain 11 and more probe
pairs which are spaced equally over the last 600 base pairs of the 3′ end
of the transcript, more global indicators of RNA degradation could be im-
plemented. The additional RNA degradation measures available for the
Affymetrix arrays include computations of probe position means and RNA
degradation slopes. The suggested average RNA degradation slopes vary
between different array types but are recommended not to exceed the av-
erage more than factor of 2.
3.3.3 The probe level model derived quality measures
The probe level quality metrics for Affymetrix microarray data are built
around the probe level model (PLM) used by RMA normalisation method.
The probe level model is a linear model for the background adjusted nor-
malised probe-level data Ygij
log(Ygij) = θˆgi + φgj + $gij
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Figure 3.2: NUSE plot of expression data from Affymetrix U133A arrays in
Paper II. The third array in a set of micrometastatic samples is an outlier
with the box-plot not being comparable with other arrays.
where θˆgi represents the log scale estimate of the expression level for gene g
on array i, φgj is the effect of the j-th probe representing gene i, and $ is the
measurement error. The θˆ in this formula is estimated robustly by median
polish and is used for computation of Relative Log Expression (RLE) and
Normalised Unscaled Standard Error (NUSE) quality metric plots.
The boxplot of RLE displays relative expression
Mgi = θˆgi −mg
of each gene g on each array i where mg is the median expression value
of gene g across all arrays. The boxes for the arrays on the box plot
represent genes which have very little difference in gene expression between
the arrays. In many situations the majority of genes between the arrays
do not change and the boxplots should have small spread centred around
M = 0. An array with quality problems may have a box with greater
spread or is not centred near 0.
NUSE values for genes g on arrays i are computed as
NUSE(θˆgi) =
SE(θˆgi)
medi(SE(θˆgi))
where SE is the standard error and medi(SE(θˆgi)) is the median of stan-
dard errors computed for array i. Similarly to RLE values, NUSE values
are shown with a box plot for each array. Lower quality arrays are likely
to have significantly elevated or more spread boxes (see Figure 3.2). The
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suggested good single number summary for the method is median NUSE
of the array.
Both RLE and NUSE produce quality metrics relative to the arrays used
in the computation and are not comparable across different datasets. The
advantage of the PLM based quality metrics over the Affymetrix standard
methods is that they are directly related to the quality of the expression
measures.
3.4 Integration and data quality
The role of quality assessment introduced in the previous section is to iden-
tify individual hybridisations with problematic quality and assure overall
data comparability. The quality measures are used to evaluate and, if neces-
sary, remove some of the data to avoid low quality and data incomparability
driven biases in consecutive data (meta-)analysis. The importance of sys-
tematic quality assessment in data integration is even higher if the data
is retrieved from different sources and has no warranty for either quality
or global level comparability. Surprisingly, data quality assessment prior
to integration is scarce. The extreme rareness of pre-integration quality
checks may partially be explained by difficulties assuring uniform quality
in cross-platform data integration, which compared to single platform ap-
proaches have been more popular. We therefore considered the large scale
systematic quality assessment of microarray data prior data integration in
Paper VI a novelty.
The methods used for quality assessment in Paper VI are summarised
in the section above. All included methods are available in R Bioconductor
and were applied, when ever possible, for each expression profile separately.
Probe level models RLE and NUSE, however, require memory intensive si-
multaneous processing of the complete data. In computations for Paper VI,
we were limited to 128 gigabytes of random access memory which, given
the size of the data, was for simultaneous RLE and NUSE assessment in-
sufficient. Hence, a heuristic was used to solve the problem. The maximum
number of arrays, given the amount of memory, that we were able to pro-
cess at one time was around 2000. We hypothesised that a sufficiently large
random sample from all arrays should closely approximate RLE and NUSE
value distributions of all of the arrays. A similar assumption for probe
level model based normalisation has been suggested by [KIL+06] and prac-
ticed in [DCD+07]. RLE and NUSE values for the data in Paper VI were
therefore computed in 5 randomly assigned batches of 1800 arrays.
An important question in quality assessment is how the quality is de-
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Figure 3.3: Histograms of values obtained for quality metrics in Paper VI.
The top row from the left contains histograms for AverageBackground,
Percent Present and Scale Factor values while the bottom row from the left
contains histograms for RNA degradation slope, RLE median and NUSE
median values.
fined. In Paper VI, the quality is firstly defined by ranges of quality metric
values suggested by [BCB+05]; and secondly, by selection of ranges for each
quality metric such that the number of good quality arrays according to
all metrics would be maximised (Figure 3.3). The range cut-offs for each
metric were selected manually and the final set of good quality arrays were
retrieved by intersection of lists of good quality arrays of each metric.
3.5 Factors proposed to affect the quality of mi-
croarray data
Several factors affecting the quality of microarray data have been suggested.
The quality of microarrays that use Cy5 label have, for instance, been shown
to fluctuate together with atmospheric ozone levels [FCD+03]. The qual-
ity of Affymetrix arrays has been demonstrated to correlate with the time
measured from the last scanner service [USGR+09]. However, most impor-
tantly, the analysis results of integrated data were shown to be influenced
by so called lab or batch effect which is expressed by higher correlation
between microarrays processed by one lab or in a batch [IWS+05] [JLR07].
The effect was also studied in Paper VI by comparison of similarities be-
30 3 Microarray data integration
0.70 0.75 0.80 0.85 0.90 0.95 1.00
0
5
10
15
Average pearson correlation distance
D
en
si
ty
Figure 3.4: Distribution of pairwise correlations between all expression
profiles in Paper VI (black), distribution of average similarities between
expression profile subgroups from different laboratories within the same
biological group (green), distribution of average similarities between ex-
pression profile subgroups from different biological groups within the same
laboratory (red).
tween expression profiles measured by laboratories that processed at least
two different types of biological material and within expression profiles of
a same biological material which came from at least two different labora-
tories (Figure 3.4). It has been demonstrated for example by [IWS+05],
that the lab effect in Affymetrix data is much smaller than in two colour
cDNA microarray data. The analysis of the data in Paper VI showed that
the lab effect may be significant but can be removed at least partially by
strict quality control and data comparability. For instance, in Paper VI, the
quality assessment lead to almost complete exclusion of initially included
Novartis human gene expression atlas data [SWB+04] which prior to global
quality assessment clustered together regardless of the diverse content of
its biological samples.
Chapter 4
Microarray data analysis
The aim of microarray data analysis is to gain new information about the
properties of the biological material and genes which expression is mea-
sured. Traditionally this is achieved by grouping of the genes and samples
based on expression similarities and identifying genes which best distin-
guish the groups of interest. This chapter discusses the methods that were
used in microarray data analysis in Papers I, II and VI. Section 4.1 in-
troduces a few distance and correlation measures that were used for data
grouping and clustering. Section 4.2 gives a brief introduction to different
data clustering methods. Section 4.3 focuses on methods used for identifi-
cation of differentially expressed genes, while section 4.4 gives a very brief
introduction to Principal Component Analysis (PCA).
4.1 Distance and correlation
In the gene expression matrix, each sample and gene could be seen as a
vector of many dimensions or a point in a higher dimensional space. In
linear algebra, the distance d between two vectors p and q of length n is
computed as
d(p, q) =
√√√√ n∑
i=1
(pi − qi)2
and is known as Euclidean distance. The closer the two points in the
Euclidean space, the smaller the distance and vice versa. Euclidean distance
is a good measure when the data is standardised by the mean and variance.
For other types of data, the correlation-based metrics are likely to perform
better.
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In Euclidean geometry, the dot product, length and angle of the vectors
are related and the angle between two vectors x and y is computed as
θ = arccos(
x · y
|x||y|).
The cosine correlation distance (or uncentered correlation coefficient)
considered in the early microarray studies [ESBB98] equals of the cosine of
the angle of the vectors x and y:
dCOR(x, y) =
x · y
|x||y| =
∑m
i=1 xiyi√∑m
i=1 x
2
i
∑m
i=1 y
2
i
The widely used Pearson correlation coefficient [Bra03]
dPEAR(x, y) =
∑m
i=1(xi − x¯)(yi − y¯)√∑m
i=1(xi − x¯)2
∑m
i=1(yi − y¯)2
could be seen as a more general form of the equation by being mean cen-
tered. The cosine correlation would then be a special case of Pearson cor-
relation with x¯ and y¯ both replaced by zero.
Similarly to other correlation measures, the Pearson correlation is in-
variant to location and scale transformations and sensitive to linear rela-
tionships between variables. However, the Pearson correlation has tendency
to be adversely affected by the outliers in which case non-parametric cor-
relation measures such as Spearman rank correlation coefficient would be
preferred.
A non-parametric Spearman rank correlation coefficient [Bra03] is sum-
marised as
ρ = dSPEAR(x, y) =
∑m
i=1(x
′
i − x¯′)(y′i − y¯′)√
summi=1(x
′
i − x¯′)2
∑m
i=1(y
′
i − y¯′)2
where x′i = rank(xi) and y′i = rank(yi). The measure differs from Pearson
correlation mainly by the operation in rank space which makes it invariant
to monotone transformations.
Microarray data is in general high dimensional data and suffers from the
curse of dimensionality [KKZ09]. In the context of distance and correlation
measures, the curse of dimensionality is expressed in less precise distance
concept as the number of dimensions grows.
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4.2 Clustering methods
Clustering is a method of unsupervised learning with the aim to assign
a set of observations into subsets called clusters based on some similarity
measure. The clustering algorithms can be either hierarchical or partitional.
4.2.1 Hierarchical clustering
Hierarchical clusters can be built successively either bottom-up (agglomer-
ative) [ESBB98] or top-down (divisive) [ABN+99].
Agglomerative hierarchical clustering starts by assigning observations
to separate clusters of one. The algorithm continues by computing dis-
tances between all clusters and merging the two closest. Re-computation
of distances and merging of the two closest clusters is repeated until either
all of the clusters are merged into one, a threshold of maximum distance,
or a preferred number of clusters is reached.
As the merged clusters contain more than one observation, different
methods exist how the distance or similarity between the groups could be
computed. The most well known of these include:
1. The minimum distance between observations of each cluster, known
as single linkage.
2. The maximum distance between observations of each cluster, known
as complete linkage.
3. The average distance between observations of each cluster, known as
average linkage.
In the context of microarray data, single linkage performs well in cases
of strong natural classes with irregular shapes. However, the method tends
to create chained or sticky clusters and therefore is not recommended for
microarray data analysis [Ste03]. The advantage of complete linkage is
production of small and compact clusters where the natural clusters in
the data are well defined. The method does not work well for fuzzy data.
The average linkage is the computationally slowest but is less influenced by
random noise and experimental error.
The disadvantages of agglomerative hierarchical clustering include dif-
ficulty to define distinct clusters, sensitivity to strong clusters which may
affect the rest of the results and unoptimised ordering of the branches of
the clustering tree.
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Figure 4.1: Hierarchical clustering of 15 groups of biological samples in
Paper VI. The average Pearson correlation distances between groups is
visualised by heatmap.
The agglomerative hierarchical clustering is often one of the first steps
in the microarray data analysis and a valued method for data visualisa-
tion. The results from hierarchical clustering are displayed as dendrograms
which illustrate the computed hierarchy between the genes (probes), sam-
ples (hybridisations) or both. The clustering dendrograms are frequently
combined with data heatmaps. Heatmaps are graphical representations of
numerical matrices where the values are transformed to colour intensities
(Figure 4.1).
Dendrograms and heatmaps are practical for visualising no more than
tens to hundreds of samples or genes. Larger number of tree branches
and data points make the interpretation of the results difficult not only
because relationships between tree branches and data points in a large
tree and heatmap are difficult to grasp but also because of unoptimised
ordering of the tree branches. In paper VI, this problem was solved by
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Figure 4.2: Heuristic for hierarchical clustering of large data matrices used
in Paper VI. Based on biological annotations of the samples, the data is
divided into sample groups which are assumed to be in average more similar
to each other than to samples in other sample groups. An input for hierar-
chical clustering is the similarity matrix of the sample groups where each
value is an average of all pairwise correlation distances between particular
two groups.
following heuristic. The data (expression measurements from all samples)
was first collapsed to groups of samples of same annotation. A similarity
distance matrix of sample groups was computed and assigned to hierarchical
clustering (see Figure 4.2).
4.2.2 K-means clustering
K-means clustering [Har75] is a partitional clustering method where dif-
ferently from hierarchical clustering, all of the clusters are determined at
once.
K-means clustering groups the data into k independent clusters. The
algorithm starts by either randomly or directly assigning the k clusters and
cluster centres (centroids) which are averages of all points in the cluster.
In the next step all of the points in the data are re-assigned to the nearest
cluster centres. Based on the new assignments, the cluster centres are re-
computed, and the procedure of assigning all of the points to the nearest
centroids and re-computation of the centroids is then repeated until some
criterion of convergence is met. A typical criterion of convergence is that
the content of the clusters between two runs of centroid re-computation
does not change.
The advantage of K-means clustering is its simplicity, the speed of com-
putation and ability to pre-define the number of clusters. The main dis-
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advantages are the difficulty to find good value for k and that the results
from any two clustering runs may not be identical as the initial assignment
of centroids is random.
K-means clustering with different k was used initially for data explo-
ration in Paper VI but was discarded after similar clusters with better data
separation were observed in Principal Component Analysis.
4.3 Differential expression
For microarray studies with measurements from two and more different
biological groups, it is natural to study how much the groups differ and
which genes between the groups drive the differential expression. This is
traditionally done by either Student’s t-test or by its derivatives or related
alternatives.
4.3.1 Student’s t-test
The student t-test is a parametric statistical test used for testing if the
means of the values obtained from two normally distributed populations
are equal under null hypothesis. The basic t-test equation:
t =
µ1 − µ2√
σ21 + σ
2
2
uses the means µ and standard deviations σ of groups 1 and 2 and assumes
equal group sizes and variances. In case these assumptions are not true, an
alternative equation, known as Welch’s t-test [Wel47],
t =
µ1 − µ2√
σ21
n1
+
σ22
n2
could be used. The standard deviations of the groups in Welch’s t-test
are corrected by the sizes of the groups ni. Depending on the data prop-
erties, other types and variants of t-test exist and could be applied. A
non-parametric alternative for t-test of unpaired groups is Mann-Whitney
U test [MW47] while Wilcoxon rank-sum test [Wil45] assumes equal sample
sizes.
4.3.2 T-test derivatives
For microarray data analysis various modifications and adjustments of the
original t-test exist. One of these, Signal to Noise metric (S2N), introduced
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by Golub and Slonim et al [GST+99] [RRLG03]:
dS2N =
µ1 − µ2
σ1 + σ2
modifies the denominator of the standard t-test to be a sum of groups
standard deviations. Modified denominator is also used by Significance
Analysis of Microarrays (SAM)[TTC01]. In SAM, the relative difference
between two sample groups is
dSAM =
µ1 − µ2
s+ s0
where s is the standard deviation and s0 a small positive constant. The
standard deviation is defined as
s =
√√√√ 1n1 + 1n2
(n1 + n2 − 2)
∑
m
[xm − x¯1]2 +
∑
n
[xn − x¯2]2
and the small positive constant s0 is chosen to minimise the coefficient of
variation.
The parametric test used for cases of more than two sample groups is
the analysis of variance (ANOVA) [KMC00]. ANOVA is a statistical test
used to test the heterogeneity of group means via analysis of the group
variances. The test can be seen as generalisation of Student’s t-test for
more than 2 groups.
S2N and SAM as well as ANOVA were used in the analysis of the data
in Paper II.
4.3.3 Permutation test
In Student’s t-test, the p-value is obtained from the t distribution. As the
underlying distribution of values can not always be assumed, other means
for obtaining the p-value exist. Permutation test [Goo00] is a type of non-
parametric significance test where the reference distribution is obtained by
calculation of all possible test results by re-arrangement of the group labels
of observed data points. In case of t-test and its derivatives, the metric
distribution is obtained by randomly assigning the data points into two
test groups. The p-value is computed as
p− valueperm = #observed
#expected
where #observed is the number of permutation results where metric value
is at least as extreme as in the original test and #expected is the number
of permutations.
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4.3.4 Multiple testing
An outcome of a statistical test is called significant if the result is unlikely
to have occurred by chance. In statistical terms it means comparison of
the test result p-value with the specified significance level 0 ≤ α ≤ 0 and
rejection of the null hypothesis in case α >p-value. Typically α is chosen
as 5% (0.05) or 1% (0.01).
In multiple testing [BY95] where certain statistical test is executed
many times over different parts of the dataset, the standard values of sig-
nificance level α, become problematic. This is because larger number of
executed tests for constant α naturally increases the number of expected
”significant” results. Several methods for the α correction in multiple test-
ing have been proposed, from which Bonferroni correction [Mil81] is the
simplest and most widely used.
In Bonferroni correction, significance level α is assigned to a set of a
size of n statistical tests. The significance level β of any single test in a set
is computed as β = α/n.
A more powerful Holm–Bonferroni [Hol79] correction adjusts the signif-
icance levels of individual tests depending on how extreme each particular
p-value in a set is. The significance for the smallest p-value is adjusted to
α/n, the second smallest α/(n− 1), and so on according to
βi =
α
n− i
where i is the position of p-value in the extremeness scale of a set.
Other multiple testing correction methods such as Benjamini-Hochberg
[BY95] exist.
4.4 Principal component analysis
Principal Component Analysis (PCA) [Jol02] is a non-parametric method
for orthogonal linear transformation of data into a new coordinate system.
The transformation is carried out such that the greatest variance by any
projection of the data is captured by the first coordinate known as the first
principal component, the second greatest variance on the second coordinate
known as second principal component, and so on.
Principal component analysis can be summarised by equation
Y = PX
where X is the data matrix of m variables in rows and n measurements
in columns and Y is the re-representation of the data X through trans-
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Figure 4.3: Principal component analysis of the data presented in Paper VI.
Each dot represents a sample from 5372 samples projected on the plane of
first and second (left), and second and third (right) principal components.
The first principal component separates hematopoietic cells from solid tis-
sues and was named hematopoietic axis. The second component separates
normal and diseased tissues, neoplastic tissues and immortal cell lines and
was named the axis of malignancy. The third component separates nervous
system related samples from the rest.
formation with matrix P . In the analysis, the orthonormal transformation
matrix P is selected such that the covariance matrix CY for Y is
CY ≡ 1n− 1Y Y
T .
Rows of matrix P are principal components of X. Geometrically, P is a
rotation and a stretch of X that results Y .
PCA relies on following assumptions:
• Linearity of the data.
• Statistical importance of mean and covariance as there is no guarantee
that the direction of maximum variance will contain good features for
discrimination.
• Large variances have important dynamics while smaller variances rep-
resent uninteresting components and noise.
Principal component analysis is used for dimensionality reduction and
recognition of the few most variable components in the data. As the less
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variable components tend to be highly correlated and have minimal contri-
bution to the total variance, these components may be dropped with the
minimal loss of information.
In context of microarray data, PCA is used both for data analysis and
visualisation (Figure 4.3). In studies with large number of measurements
the global differences between biological samples are often visualised by the
projection of pairs of first few principal components on planes or in three
dimensional space [DCD+07][KAO+08][SBD+05][GBL+08].
Chapter 5
Analysis of human melanoma data
Melanoma is a malignant tumour of melanocytes [Ali02] [CFBM69] [Bre70].
It is mainly found on skin, but also in the eye (uveal melanoma) and bowel.
Melanoma is more common among Caucasians living in sunny climates and
in females. The number of melanoma related death is, however, higher in
males [PBFP05]. Melanoma is one of the less common types of skin can-
cer but responsible for majority of skin cancer related deaths [LMSA06].
The prognosis with regional metastasis is poor and occurrence of distant
metastasis refers to a largely incurable disease [LMSA06] [Rus00]. The
mechanisms of melanoma metastasation are not clear making early diag-
nosis vital for patients.
This chapter is an introduction to Papers I and II which contribute to
the research of melanoma progression and diagnostics. Section 5.1 provides
outline for the sentinel lymph node based melanoma diagnostics. Section
5.2. describes the data preparation for the analysis in Paper II and Section
5.3 will give a rationale for the usage of fold change method in determination
of the differentially expressed genes in Paper I.
5.1 Sentinel lymph node based melanoma diag-
nostics
Since the formal acknowledgment in 1840, it generally still holds true that
the chance of survival from melanoma is dependent upon the early removal
of the disease by operation [Coo40]. In 1892, Herbert Snow introduced an
opportunity to improve the survival of melanoma patients by wide excision
and elective lymph node dissection [Sno92]. The essence of this method
was to control the lymphatic permeation of melanoma metastases. One
hundred years later, in 1992, dissatisfaction with the procedure lead to a
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development of a new, finer technique, known as intraoperative lymphatic
mapping and sentinel lymphadenectomy [MWW+92] [CWM92]. The lym-
phatic mapping exploits the hypothesis that the dermal lymphatics provide
direct connection from the primary melanoma to regional lymph field. The
sentinel lymph node, the closest to the primary site of melanoma, is hence
the first regional site for melanoma metastasis. Sentinel lymphadenectomy,
meaning systematic removal of sentinel lymph nodes, is practiced as a pre-
ventive measure to stop disease progression while also providing tissue ma-
terial for more accurate disease staging.
Despite the controversy about the benefits of sentinel lymphadenectomy
criticised for example by [Tho05] [Tho07] and existing clinical alternatives
[VvASH+09], histologic sentinel lymph node examination has become a
standard of care [Cas99].
5.2 A global search of metastatic melanoma spe-
cific marker genes
Histologic examination of sentinel lymph nodes is time consuming and
error-prone. Hence, alternative RT-PCR based assays for melanoma cell
detection in sentinel lymph nodes have been suggested. The goal in Pa-
per II was to construct such an assay using a list of metastatic melanoma
specific genes identified by a transcriptome wide gene expression study.
The transcriptome wide coverage in Paper II was achieved by usage of two
Affymetrix arrays, HG-133A and HG-U133B, known as HG-U133Set. The
material from studied biological material was hybridised on both of the
arrays, which in the light of integration issues discussed in Chapter 3, was
a source of problems in the analysis.
It is important to note that the data available for the analysis were
MAS5 intensities from Affymetrix CHP files. The main questions prior to
analysis were: 1) if the data should be somehow pre-processed and 2) if
the analysis should be carried out on both arrays separately or the data
from two array platforms should be first integrated. Given that the material
hybridised to HG-U133A array (A array) had a fixed volume while material
hybridised on HG-U133B array (B array) had a variable volume, depending
on how much material was left over from the hybridisation to A array, it was
hypothesised that observed expression values in B arrays may be volume
biased. As the A and B arrays share a set of 100 identical control probe
sets, we hypothesised that these could be used in detection and correction
of the possible material volume induced expression biases in B arrays. The
bias was estimated and corrected by computing a ratio of mean expressions
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Figure 5.1: Pre-processing of the microarray data in Papers I and II.
of shared probe sets in A and B arrays and multiplying the values in B
arrays by the computed factor. The adjusted expression values of B arrays
were then merged with the data from A arrays into joint virtual AB arrays
and the data from all virtual AB arrays was combined to one data matrix
(Figure 5.1).
We also realised that depending on the amount of material hybridised
to B arrays, the scales of A arrays and the combined virtual AB arrays
may need further adjustment. It is reasonable to assume that the amount
of mRNA produced in an average cell or tissue type are comparable. Hence,
the adjustment of the scales of individual arrays to the same level is justi-
fied. The scales of the AB arrays in the joint data matrix in Paper II were
equalised by quantile normalisation for which the method was implemented
in C according to [BIAS03].
The methods and measures used for identification of differentially ex-
pressed genes for the construction of PCR assay in Paper II have already
been covered in Chapter 4. However, the final selection of genes for the
PCR assay was performed considering statistical significance as well as fold
change and biological significance.
5.3 For the justification of fold change usage
Genes tenascin-C, fibronectin, and procollagen-I in the centre of Paper I
were identified in microarray data as differentially expressed using the fold
change.
The microarray literature knows two different definitions of fold change.
44 5 Analysis of human melanoma data
The fold change Fratio of a gene i is usually referred as
Fratio =
x¯i
y¯i
where xi and yi are the expression levels of the gene in two groups of sam-
ples, while fold change in [CBM+05] and [GLW+06] has also been referred
as
Fdiff = x¯i − y¯i.
Importantly, depending on the definition of the signal, for instance in
log space log(a/b) = log(a)− log(b), the fold changes of both measures may
be the same. In Papers I and II, the fold was defined as Fratio even though
for manuscript preparation, both Fratio and Fdiff were computed.
The use of fold change among biologists has been criticised and the usage
of more sophisticated methods for identification of differentially expressed
genes, such as t-test and its derivatives, have been promoted. A problem
in using fold change is the difficulty in defining if genes of certain fold
are significantly differentially expressed as the widely used two or three
fold significance cut-off levels are mere suggestions. However, it has been
shown that fold change in selection of differentially expressed genes not
only performs well but has very high rate of reproducibility (> 90%) while
usage of t-test derived p-values correlates with reproducibility [GLW+06]
[STF+05] [SRJ+06] [PLFS+06]. A positive correlation between higher fold
change and better reproducibility has been observed, while results from
smaller fold changes are less likely to reproduce well. Furthermore, the
impact of the normalisation methods on the reproducibility of the gene
lists in fold change is minimal compared to p values and global scaling
of the data differently from p values does not influence the results. While
comparing three methods: t-test, SAM and fold change [GLW+06], the fold
change from the three in finding differentially expressed genes is reportedly
superior; though concordance based on SAM was clearly improved over
that of the simple t-test. Witten and Tibshirani [WT07] have additionally
studied the matter, both on simulated as well as on real data, and showed
that SAM and fold change clearly outperform the simple t-test, and that the
behaviour of two versions of fold change are quite similar. They also point
out if absolute changes in expression are relevant, like for instance in Paper
I, fold change should be used. Based on this evidence, MAQC suggests fold
change assessment together with a non-stringent p-value cutoff [SRJ+06].
We therefore found the usage of fold change in papers I and II justifiable.
Chapter 6
Summary and Conclusions
In this thesis we constructed a global map of human gene expression and
studied its structure. We also identified genes which are involved in human
melanoma metastasation, carried out genome-wide search of metastatic
melanoma specific genes in the context of normal lymph tissue and demon-
strated that found genes work well in a clinical assay in detection of melanoma
metastasis in sentinel lymph nodes.
The three groups of computational problems assessed in this thesis were
problems with DNA microarray data retrieval and formats, problems with
microarray data integration, and problems in microarray data analysis and
visualisation.
Construction of a global map of human gene expression required a vast
amount of gene expression data. The source of these data are public mi-
croarray data repositories, such as GEO and ArrayExpress. The data used
in this thesis originated from these two databases. Retrieval, processing,
re-formatting and cleaning of these data from both of the databases, but es-
pecially from ArrayExpress, both computationally as well as manually, was
perhaps the most time consuming part of the work invested to this thesis.
Even though the access to the data in ArrayExpress has been significantly
improved, a large scale microarray data retrieval and local organisation
will remain an exercise of scripting and local data organisation even in the
future.
The challenge in microarray data integration assessed in this thesis was
in assurance of integrity and comparability of both numerical expression
values as well as the accompanying microarray meta-data. The general
approach taken was new even though most of the applied methods were
well known. The consistency of numerical expression measurements was
ensured by computation of series of data quality metrics and selection of
expression profiles with quality metric values within a range of comparable
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hand picked metric cut-offs. A possible improvement here would be a selec-
tion of ranges of cut-offs for each metric computationally e.g. by dynamic
programming as it would assure the maximisation of the the amount of
comparable expression profiles globally.
The problem in the microarray meta-data integration was identification
of information rich keywords in GEO free text sample annotation records
and converting these into MGED Ontology compatible microarray sample
annotations. This was solved by creation of custom ontology of MGED
Ontology derived sample categories and lists of keywords and regular ex-
pressions for each category. The keywords were searched in GEO free text
sample and experiment entries, categories were assigned according to identi-
fied keywords and keyword category pairs were then made subject of either
selection or rejection depending on their context of occurrence. The main
weakness of this approach was the incompleteness of the ontology and in
some cases lack of descriptiveness of the original annotation text. While for
the latter there is no cure, the approach may be improved by usage of now
available Experimental Factor Ontology [MHA+10]. This ontology is devel-
oped by a team of dedicated ontologists especially for managing microarray
sample annotations and is therefore likely to produce better results with
less manual curation required in the end.
Microarray data analysis is an active field of research with often more
than one method available to solve any one type of problem. Which of the
methods to choose is, however, not always clear. This is also reflected in
this thesis. For instance, the lists of differentially expressed genes in the
included papers were computed by fold change, SAM, and limma [Smy05];
with t-test, S2N and other methods considered and practiced in parallel. In
each case, the decision of which method or methods to use use was driven
by authors confidence for the deliverance of most accurate results.
The arsenal of traditional microarray data partitioning and visualisa-
tion methods is, however, more limited. The methods of choice include
hierarchical agglomerative clustering, heatmaps, and K-means clustering,
while PCA, Self Organising Maps (SOM) [Koh95] and other methods are
used less frequently. In this thesis, partitioning and visual exploration of
the data of a human map of gene expression by hierarchical agglomerative
clustering proved a challenge. While majority of the microarray studies ap-
ply hierarchical clustering from tens to hundreds of samples, our data was
captured in a data matrix of 5300 x 22000. A question if usage of hierar-
chical clustering under such circumstance would be practical and justified
was asked. Our experience, however, showed that usage of other methods,
such as NeRV [VK07] or Principal Component Analysis alone did not of-
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fer the amount of exploratory flexibility and detail that one would have
anticipated. Hence the usage of heuristic to collapse the data by another
data derived sample ontology and still use the agglomerative hierarchical
clustering, now on a matrix of average pairwise correlation distances of on-
tology defined sample groups. The clustering could have been carried out
also differently, for instance by implementation of hierarchical agglomera-
tive clustering algorithm where the inputs are the full data and pre-defined
ontology derived sample groups. In such implementation, the clustering
would start from pre-defined sample groups and data collapsing prior to
clustering would not be necessary.
- - -
In summary, this thesis contributed to the fields of bioinformatics and
computational biology by the tools developed; improved data display and
access to one of the largest public microarray data repository; and by new
techniques and heuristics for large scale microarray data integration and
analysis. This thesis also contributed to cancer and systems biology by its
new findings reported by included papers. This thesis demonstrated the
richness of data accumulated in public microarray data repositories and
showed one way of unlocking it. This thesis also demonstrated compu-
tational difficulties of working with large quantities of diverse microarray
data, and shows how existing data processing and analysis methods can be
combined and may need adjustments to reach the goal. The work included
points to the need of improved biomedical and specialised ontologies which
are curtail for working with large microarray datasets, and limitations of
current algorithms which, while working with large integrated microarray
datasets, can barely deliver the results even in a large computers not ac-
cessible for an average user. Finally, this work exhibits the diversity of
skills from general programming and working with relational databases, to
statistics, data and text mining, ontology building, good understanding of
human anatomy and physiology, cell and molecular biology and wet lab
procedures used in microarray data generation which all are needed while
working on the field of microarray informatics.
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